In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
about
An approach to identifying drug resistance associated mutations in bacterial strainsHigh incidence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with bovine mastitis in China.Whole-genome analysis of an oxacillin-susceptible CC80 mecA-positive Staphylococcus aureus clinical isolate: insights into the mechanisms of cryptic methicillin resistance.Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.Linezolid dependence in Staphylococcus epidermidis bloodstream isolatesActivity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.The challenges of antimicrobial drug resistance in Greece.Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa.Genotypic resistance testing creates new treatment challenges: two cases of oxacillin-susceptible methicillin-resistant Staphylococcus aureus.Detection of oxacillin-susceptible mecA-positive Staphylococcus aureus isolates by use of chromogenic medium MRSA IDOxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK.Oxacillin-susceptible MRSA: could it become a successful MRSA type?Prevalence, antimicrobial resistance, and virulence characteristics of mecA-encoding coagulase-negative staphylococci isolated from soft cheese in Brazil.
P2860
Q34530052-6F99E735-06B4-46AF-AACE-E50EEDCD49F7Q35093565-A37DFE6A-AFCC-4985-BAA7-0294313D5B17Q35703993-A83621D8-318A-4EC2-A15C-BE240CB20E99Q36018823-7A35A08E-9337-49C5-AB2B-7EAD6E1FAD40Q36570794-9F1BA3AD-84AB-431D-BB0C-1F3EB9D3D7F5Q37335672-00AECA2B-51BD-43CE-BFC2-629C3913FBDCQ37392891-FCEEFBBC-4020-4074-9D1C-974349DB672CQ37892237-4707DBD5-6854-47FB-9E61-B6EA87BD58A5Q40640020-415A2DD7-22A8-4B81-969E-E830A4057456Q41637328-9BD1464C-A081-448B-9284-F24C4FE36987Q41845134-BFF9567D-08D1-49C4-B397-C9AADB89EE3CQ42210949-9D033B85-5B10-4C3A-A4CF-6F3FDDF21F24Q44549132-E216DD69-1319-4A49-82C0-5E592F699CF3Q44879939-1F43A7B9-3091-43CB-865A-B614EE629C17
P2860
In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In vitro and in vivo evaluatio ...... eptible Staphylococcus aureus.
@en
type
label
In vitro and in vivo evaluatio ...... eptible Staphylococcus aureus.
@en
prefLabel
In vitro and in vivo evaluatio ...... eptible Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
In vitro and in vivo evaluatio ...... eptible Staphylococcus aureus.
@en
P2093
Afroditi Vasdeki
Alexandros Ikonomidis
Antonios N Maniatis
Constantinos Stathopoulos
George Michail
Maria Labrou
Spyros Pournaras
Vasilis Karavasilis
P2860
P304
P356
10.1128/AAC.00653-08
P407
P577
2008-08-11T00:00:00Z